Solengepras

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameSolengepras
Drug Alias NameCVN-424
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 6 antagonists
TargetsG-protein coupled receptor 6
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[9] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCerevance LLC
China Registration ClassN/A

Develop Information

Active CompaniesCerevance LLCCerevance Beta Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A